Dominik J Schaer
The HeMoVal study protocol: a prospective international multicenter cohort study to validate cerebrospinal fluid hemoglobin as a monitoring biomarker for aneurysmal subarachnoid hemorrhage related secondary brain injury.
Akeret K, Buzzi R, Saxenhofer M, Bieri K, Chiavi D, Thomson B, Grüttner-Durmaz M, Schwendinger N, Humar R, Regli L, van Doormaal T, Held U, Keller E, Hugelshofer M, Schaer D, Hostettler I. The HeMoVal study protocol: a prospective international multicenter cohort study to validate cerebrospinal fluid hemoglobin as a monitoring biomarker for aneurysmal subarachnoid hemorrhage related secondary brain injury. BMC Neurol 2022; 22:267.
18.07.2022The HeMoVal study protocol: a prospective international multicenter cohort study to validate cerebrospinal fluid hemoglobin as a monitoring biomarker for aneurysmal subarachnoid hemorrhage related secondary brain injury.
18.07.2022BMC Neurol 2022; 22:267
Akeret Kevin, Buzzi Raphael, Saxenhofer Moritz, Bieri Kathrin, Chiavi Deborah, Thomson Bart R, Grüttner-Durmaz Manuela, Schwendinger Nina, Humar Rok, Regli Luca, van Doormaal Tristan P C, Held Ulrike, Keller Emanuela, Hugelshofer Michael, Schaer Dominik J, Hostettler Isabel C
Clinical outcomes in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: a retrospective analysis of results from the OBSErve study in Switzerland
von Kempis J, Duetsch S, Reuschling N, Villiger R, Villiger P, Vallelian F, Schaer D, Mueller R. Clinical outcomes in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: a retrospective analysis of results from the OBSErve study in Switzerland. Swiss Med Wkly 2019; 149:w20022.
10.03.2019Clinical outcomes in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: a retrospective analysis of results from the OBSErve study in Switzerland
10.03.2019Swiss Med Wkly 2019; 149:w20022
von Kempis Johannes, Duetsch Sabine, Reuschling Nicola, Villiger Rahel, Villiger Peter M, Vallelian Florence, Schaer Dominik J, Mueller Ruediger B
Cell-Free Oxyhemoglobin in Cerebrospinal Fluid After Aneurysmal Subarachnoid Hemorrhage: Biomarker and Potential Therapeutic Target.
Hugelshofer M, Sikorski C, Seule M, Deuel J, Muroi C, Seboek M, Akeret K, Buzzi R, Regli L, Schaer D, Keller E. Cell-Free Oxyhemoglobin in Cerebrospinal Fluid After Aneurysmal Subarachnoid Hemorrhage: Biomarker and Potential Therapeutic Target. World Neurosurg 2018; 120:e660-e666.
27.08.2018Cell-Free Oxyhemoglobin in Cerebrospinal Fluid After Aneurysmal Subarachnoid Hemorrhage: Biomarker and Potential Therapeutic Target.
27.08.2018World Neurosurg 2018; 120:e660-e666
Hugelshofer Michael, Sikorski Christopher M, Seule Martin, Deuel Jeremy, Muroi Carl I, Seboek Martina, Akeret Kevin, Buzzi Raphael, Regli Luca, Schaer Dominik J, Keller Emanuela
[Systemic glucocorticoids: diagnosis, prophylaxis and treatment of side effects].
Ritter A, Burow A, Vallelian F, Schaer D. [Systemic glucocorticoids: diagnosis, prophylaxis and treatment of side effects]. Praxis (Bern 1994) 2014; 103:987-98; quiz 996.
20.08.2014[Systemic glucocorticoids: diagnosis, prophylaxis and treatment of side effects].
20.08.2014Praxis (Bern 1994) 2014; 103:987-98; quiz 996
Ritter Alexander, Burow Annika, Vallelian Florence, Schaer Dominik J